Utilization of new national preparation ‘Dioxomast' to treat subclinical mastitis of cows in lactation period
Dysfunction of mammary gland significantly damages dairy cattle breeding. At this disease milk productivity decreases and milk quality worsens obviously. Utilization of the national effective and inexpensive anti-mastitis preparations can influence the disease frequency, treatment costs and losses at milk withdrawal. Together with experimental technology-based firm «ETRIS» the control sample of new anti-mastitis preparation designed to treat cows mastitis during lactation period and which will not cause any adverse effects of cows. Investigations on studying the therapeutic efficiency of new anti-mastitis preparation ”Diox-omasf ' were carried out in the manufacturing environment at milk production farms Self-Employed Entrepreneur Kos'kina 1.1., located in the Bolkhov district of the Orel region. Detection and treatment of ill cows with mastitis was done according to diagnostics recommendations, therapy and preventive measures of mastitis of cows. In milk samples the mastitis agents: agalactiae streptococcus, staphylococcus aureus, staphylococcus hominis and colibacillus were detected. To study the therapeutic properties and influence of new preparation on lactating cows organism two cows groups were selected. The first group was treated with new preparation and the second group with well known antimastitis preparation which in spite of its high medical properties, it can cause some adverse effects in cow organism. At the end of treatment with ”Diox-omast” 10 from 12 cows (17 from 20 udder segments) recovered. Treatment efficiency was 83-85%. At the same time the adhesive effects were not detected among the animals being treated with new preparation.